The Influence of Renal Function on Clinical Outcome and Response to β-Blockade in Systolic Heart Failure: Insights From Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF)
Jalal K. Ghali(Launchpad Central (United States)), Hans Wedel(Sahlgrenska University Hospital), Sidney Goldstein(Sahlgrenska University Hospital), Lis Ohlsson(AstraZeneca (Sweden)), Finn Waagstein(Apple (Israel)), Björn Fagerberg(Sahlgrenska University Hospital), John Wikstrand(Nuffield Health), Ola Samuelsson(University of Gothenburg), Dirk J. van Veldhuisen(University Medical Center Groningen), Peter Johansson(Linköping University), Åke Hjalmarson(Apple (Israel)), John Kjekshus(Nuffield Health)
Cited by 108
Related Papers
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
|The Lancet|1998|5.8k
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
|The Lancet|2002|5.4k
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
|New England Journal of Medicine|2007|4.6k
Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery
|New England Journal of Medicine|2004|4.5k
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
|European Heart Journal|2015|3.9k